The last frontier: transcatheter devices for percutaneous or minimally invasive treatment of chronic heart failure


Heart failure has a high prevalence in the general population. Morbidity and mortality of heart failure patients remain high, despite improvements in drug therapy, implantable cardioverter-defibrillators and cardiac resynchronisation therapy. New transcatheter implantable devices have been developed to improve the treatment of heart failure. There has been… (More)
DOI: 10.1007/s12471-017-1018-8

8 Figures and Tables


  • Presentations referencing similar topics